UBS Group’s Langar Global HealthTech ETF LGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.13K Sell
590
-113
-16% -$1.09K ﹤0.01% 8833
2025
Q4
$7.03K Buy
703
+201
+40% +$2.04K ﹤0.01% 8485
2025
Q3
$5.05K Buy
502
+413
+464% +$4.25K ﹤0.01% 8902
2025
Q2
$927 Buy
+89
New +$882 ﹤0.01% 9706
2025
Q1
Sell
-212
Closed -$2.15K 10506
2024
Q4
$2.15K Buy
+212
New +$2.22K ﹤0.01% 9101
2024
Q3
Sell
-10
Closed -$103 9820
2024
Q2
$103 Buy
+10
New +$104 ﹤0.01% 9157

Other funds holding LGHT

UBS Group's LGHT Position: Q1 2026 in Review

UBS Group reduced its Langar Global HealthTech ETF (LGHT) stake by 16% in Q1 2026, selling an estimated $1.09K and leaving 590 shares worth $5.13K. The position accounts for ﹤0.01% of the portfolio, ranked #8833.

UBS Group first reported a position in LGHT in Q2 2024 and has held it in 6 quarters since. The position peaked at $7.03K in Q4 2025. 6 funds tracked by Wall St. Rank hold LGHT as of Q1 2026.

  • UBS Group held 590 shares of Langar Global HealthTech ETF worth $5.13K as of Q1 2026.
  • UBS Group sold 113 Langar Global HealthTech ETF shares in Q1 2026, an estimated $1.09K.
  • Langar Global HealthTech ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8833 holding.
  • UBS Group first reported a position in Langar Global HealthTech ETF in Q2 2024 and has held it in 6 quarters since.
  • UBS Group's Langar Global HealthTech ETF position peaked at $7.03K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Langar Global HealthTech ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.